Announcement on Using Temporarily Idle Raised Funds for Cash Management
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Using Temporarily Idle Raised Funds for Cash Management
Filed with SSE · · 5 pages · Chinese
Release
Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jiangsu Aidea Pharmaceutical
- Announcement on Early Return of Remaining Idle Raised Funds Used to Temporarily Supplement Current Capital
- Earnings Preannouncement for 2025
- Announcement on Voluntary Disclosure of Notice of Approval for Drug Clinical Trial Application Obtained by ADC205 Tablets
- Indicative Announcement on Disclosure of Plan for Issuing A-Shares to Specific Objects by Summary Procedures in 2026
- Announcement on Estimated Amount of Daily Related Party Transactions in 2026
Later from Jiangsu Aidea Pharmaceutical
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Share Increase Plan of Actual Controller
- Announcement on Penalties or Regulatory Measures Imposed by Securities Regulatory Authorities and Stock Exchanges in the Recent Five Years
- Announcement on Voluntary Disclosure of Obtained Patent Certificates in Japan
- Announcement on Cancellation of Special Settlement Accounts for Some Raised Fund Financial Products
Follow Jiangsu Aidea Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Aidea Pharmaceutical